Cargando…

Evidence for inefficient contraction and abnormal mitochondrial activity in sarcopenia using magnetic resonance spectroscopy

BACKGROUND: Mitochondrial dysfunction has been implicated in sarcopenia. (31)P magnetic resonance spectroscopy (MRS) enables non‐invasive measurement of adenosine triphosphate (ATP) synthesis rates to probe mitochondrial function. Here, we assessed muscle energetics in older sarcopenic and non‐sarco...

Descripción completa

Detalles Bibliográficos
Autores principales: Stephenson, Mary C., Ho, Jamie X.M., Migliavacca, Eugenia, Kalimeri, Maria, Karnani, Neerja, Banerji, Subhasis, Totman, John J., Feige, Jerome N., Merchant, Reshma A., Tay, Stacey K.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235891/
https://www.ncbi.nlm.nih.gov/pubmed/37143433
http://dx.doi.org/10.1002/jcsm.13220
_version_ 1785052796008005632
author Stephenson, Mary C.
Ho, Jamie X.M.
Migliavacca, Eugenia
Kalimeri, Maria
Karnani, Neerja
Banerji, Subhasis
Totman, John J.
Feige, Jerome N.
Merchant, Reshma A.
Tay, Stacey K.H.
author_facet Stephenson, Mary C.
Ho, Jamie X.M.
Migliavacca, Eugenia
Kalimeri, Maria
Karnani, Neerja
Banerji, Subhasis
Totman, John J.
Feige, Jerome N.
Merchant, Reshma A.
Tay, Stacey K.H.
author_sort Stephenson, Mary C.
collection PubMed
description BACKGROUND: Mitochondrial dysfunction has been implicated in sarcopenia. (31)P magnetic resonance spectroscopy (MRS) enables non‐invasive measurement of adenosine triphosphate (ATP) synthesis rates to probe mitochondrial function. Here, we assessed muscle energetics in older sarcopenic and non‐sarcopenic men and compared with muscle biopsy‐derived markers of mitochondrial function. METHODS: Twenty Chinese men with sarcopenia (SARC, age = 73.1 ± 4.1 years) and 19 healthy aged and sex‐matched controls (CON, age = 70.3 ± 4.2 years) underwent assessment of strength, physical performance, and magnetic resonance imaging. Concentrations of phosphocreatine (PCr), ATP and inorganic phosphate (Pi) as well as muscle pH were measured at rest and during an interleaved rest–exercise protocol to probe muscle mitochondrial function. Results were compared to biopsy‐derived mitochondrial complex activity and expression to understand underlying metabolic perturbations. RESULTS: Despite matched muscle contractile power (strength/cross‐sectional area), the ATP contractile cost was higher in SARC compared with CON (low‐intensity exercise: 1.06 ± 0.59 vs. 0.57 ± 0.22, moderate: 0.93 ± 0.43 vs. 0.58 ± 0.68, high: 0.70 ± 0.57 vs. 0.43 ± 0.51 mmol L(−1) min(−1) bar(−1) cm(−2), P = 0.003, <0.0001 and <0.0001, respectively). Post‐exercise mitochondrial oxidative synthesis rates (a marker of mitochondrial function) tended to be longer in SARC but did not reach significance (17.3 ± 6.4 vs. 14.6 ± 6.5 mmol L(−1) min(−1), P = 0.2). However, relative increases in end‐exercise ADP in SARC (31.8 ± 9.9 vs. 24.0 ± 7.3 mmol L(−1), P = 0.008) may have been a compensatory mechanism. Mitochondrial complex activity was found to be associated with exercise‐induced drops in PCr [citrate synthetase activity (CS), Spearman correlation rho = −0.42, P = 0.03] and end‐exercise ADP (complex III, rho = −0.52, P = 0.01; CS rho = −0.45, P = 0.02; SDH rho = −0.45, P = 0.03), with CS also being strongly associated with the PCr recovery rate following low intensity exercise (rho = −0.47, P = 0.02), and the cost of contraction at high intensity (rho = −0.54, P = 0.02). Interestingly, at high intensity, the fractional contribution of oxidative phosphorylation to exercise was correlated with activity in complex II (rho = 0.5, P = 0.03), CS (rho = 0.47, P = 0.02) and SDH (rho = 0.46, P = 0.03), linking increased mitochondrial complex activity with increased ability to generate energy through oxidative pathways. CONCLUSIONS: This study used (31)P MRS to assess ATP utilization and resynthesis in sarcopenic muscle and demonstrated abnormal increases in the energy cost during exercise and perturbed mitochondrial energetics in recovery. Associations between mitochondrial complex activity and the fractional contribution to energy requirement during exercise indicate increased ability to generate energy oxidatively in those with better mitochondrial complex activity.
format Online
Article
Text
id pubmed-10235891
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102358912023-06-03 Evidence for inefficient contraction and abnormal mitochondrial activity in sarcopenia using magnetic resonance spectroscopy Stephenson, Mary C. Ho, Jamie X.M. Migliavacca, Eugenia Kalimeri, Maria Karnani, Neerja Banerji, Subhasis Totman, John J. Feige, Jerome N. Merchant, Reshma A. Tay, Stacey K.H. J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: Mitochondrial dysfunction has been implicated in sarcopenia. (31)P magnetic resonance spectroscopy (MRS) enables non‐invasive measurement of adenosine triphosphate (ATP) synthesis rates to probe mitochondrial function. Here, we assessed muscle energetics in older sarcopenic and non‐sarcopenic men and compared with muscle biopsy‐derived markers of mitochondrial function. METHODS: Twenty Chinese men with sarcopenia (SARC, age = 73.1 ± 4.1 years) and 19 healthy aged and sex‐matched controls (CON, age = 70.3 ± 4.2 years) underwent assessment of strength, physical performance, and magnetic resonance imaging. Concentrations of phosphocreatine (PCr), ATP and inorganic phosphate (Pi) as well as muscle pH were measured at rest and during an interleaved rest–exercise protocol to probe muscle mitochondrial function. Results were compared to biopsy‐derived mitochondrial complex activity and expression to understand underlying metabolic perturbations. RESULTS: Despite matched muscle contractile power (strength/cross‐sectional area), the ATP contractile cost was higher in SARC compared with CON (low‐intensity exercise: 1.06 ± 0.59 vs. 0.57 ± 0.22, moderate: 0.93 ± 0.43 vs. 0.58 ± 0.68, high: 0.70 ± 0.57 vs. 0.43 ± 0.51 mmol L(−1) min(−1) bar(−1) cm(−2), P = 0.003, <0.0001 and <0.0001, respectively). Post‐exercise mitochondrial oxidative synthesis rates (a marker of mitochondrial function) tended to be longer in SARC but did not reach significance (17.3 ± 6.4 vs. 14.6 ± 6.5 mmol L(−1) min(−1), P = 0.2). However, relative increases in end‐exercise ADP in SARC (31.8 ± 9.9 vs. 24.0 ± 7.3 mmol L(−1), P = 0.008) may have been a compensatory mechanism. Mitochondrial complex activity was found to be associated with exercise‐induced drops in PCr [citrate synthetase activity (CS), Spearman correlation rho = −0.42, P = 0.03] and end‐exercise ADP (complex III, rho = −0.52, P = 0.01; CS rho = −0.45, P = 0.02; SDH rho = −0.45, P = 0.03), with CS also being strongly associated with the PCr recovery rate following low intensity exercise (rho = −0.47, P = 0.02), and the cost of contraction at high intensity (rho = −0.54, P = 0.02). Interestingly, at high intensity, the fractional contribution of oxidative phosphorylation to exercise was correlated with activity in complex II (rho = 0.5, P = 0.03), CS (rho = 0.47, P = 0.02) and SDH (rho = 0.46, P = 0.03), linking increased mitochondrial complex activity with increased ability to generate energy through oxidative pathways. CONCLUSIONS: This study used (31)P MRS to assess ATP utilization and resynthesis in sarcopenic muscle and demonstrated abnormal increases in the energy cost during exercise and perturbed mitochondrial energetics in recovery. Associations between mitochondrial complex activity and the fractional contribution to energy requirement during exercise indicate increased ability to generate energy oxidatively in those with better mitochondrial complex activity. John Wiley and Sons Inc. 2023-05-04 /pmc/articles/PMC10235891/ /pubmed/37143433 http://dx.doi.org/10.1002/jcsm.13220 Text en © 2023 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Stephenson, Mary C.
Ho, Jamie X.M.
Migliavacca, Eugenia
Kalimeri, Maria
Karnani, Neerja
Banerji, Subhasis
Totman, John J.
Feige, Jerome N.
Merchant, Reshma A.
Tay, Stacey K.H.
Evidence for inefficient contraction and abnormal mitochondrial activity in sarcopenia using magnetic resonance spectroscopy
title Evidence for inefficient contraction and abnormal mitochondrial activity in sarcopenia using magnetic resonance spectroscopy
title_full Evidence for inefficient contraction and abnormal mitochondrial activity in sarcopenia using magnetic resonance spectroscopy
title_fullStr Evidence for inefficient contraction and abnormal mitochondrial activity in sarcopenia using magnetic resonance spectroscopy
title_full_unstemmed Evidence for inefficient contraction and abnormal mitochondrial activity in sarcopenia using magnetic resonance spectroscopy
title_short Evidence for inefficient contraction and abnormal mitochondrial activity in sarcopenia using magnetic resonance spectroscopy
title_sort evidence for inefficient contraction and abnormal mitochondrial activity in sarcopenia using magnetic resonance spectroscopy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235891/
https://www.ncbi.nlm.nih.gov/pubmed/37143433
http://dx.doi.org/10.1002/jcsm.13220
work_keys_str_mv AT stephensonmaryc evidenceforinefficientcontractionandabnormalmitochondrialactivityinsarcopeniausingmagneticresonancespectroscopy
AT hojamiexm evidenceforinefficientcontractionandabnormalmitochondrialactivityinsarcopeniausingmagneticresonancespectroscopy
AT migliavaccaeugenia evidenceforinefficientcontractionandabnormalmitochondrialactivityinsarcopeniausingmagneticresonancespectroscopy
AT kalimerimaria evidenceforinefficientcontractionandabnormalmitochondrialactivityinsarcopeniausingmagneticresonancespectroscopy
AT karnanineerja evidenceforinefficientcontractionandabnormalmitochondrialactivityinsarcopeniausingmagneticresonancespectroscopy
AT banerjisubhasis evidenceforinefficientcontractionandabnormalmitochondrialactivityinsarcopeniausingmagneticresonancespectroscopy
AT totmanjohnj evidenceforinefficientcontractionandabnormalmitochondrialactivityinsarcopeniausingmagneticresonancespectroscopy
AT feigejeromen evidenceforinefficientcontractionandabnormalmitochondrialactivityinsarcopeniausingmagneticresonancespectroscopy
AT merchantreshmaa evidenceforinefficientcontractionandabnormalmitochondrialactivityinsarcopeniausingmagneticresonancespectroscopy
AT taystaceykh evidenceforinefficientcontractionandabnormalmitochondrialactivityinsarcopeniausingmagneticresonancespectroscopy